Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2

Anna Vihola1, Linda L Bachinski, Mario Sirito

  • 1Department of Medical Genetics, Folkhälsan Institute of Genetics, University of Helsinki, 00014 Helsinki, Finland.

Acta Neuropathologica
|January 13, 2010
PubMed

Insights

Myotonic dystrophies type 1 and 2 (DM1 and DM2) show distinct molecular differences in gene splicing and myosin expression, impacting muscle function. These findings offer new insights into the varying muscle involvement in DM1 and DM2.

Area of Science:

  • Molecular Biology
  • Genetics
  • Neuromuscular Disorders

Background:

  • Myotonic dystrophies type 1 (DM1) and type 2 (DM2) share complex phenotypes, but the precise molecular basis for muscle weakness and differential muscle involvement remains unclear.
  • RNA-mediated toxic gain-of-function is implicated in DM1 and DM2 pathogenesis, affecting gene transcription and mRNA processing.

Purpose of the Study:

  • To investigate the molecular differences in gene expression and splicing between DM1 and DM2.
  • To elucidate the molecular basis of muscle weakness and differential muscle involvement in DM1 and DM2.

Main Methods:

  • Microarray profiling of mRNA expression for muscle-specific genes and transcription factors.
  • Analysis of abnormal splicing in selected genes.
  • Protein level analysis of abnormally regulated genes.

Main Results:

  • Differential abnormal splicing of TNNT3 and LDB3 genes observed, with more pronounced patterns in DM2 compared to DM1.
  • Global abnormalities in myosin isoforms, including increased transcript levels in both DM1 and DM2.
  • Distinct myosin isoform expression in atrophic muscle fibers: DM2 exclusively fast myosin, DM1 co-expression of fast and slow myosin.

Conclusions:

  • Abnormal splicing of TNNT3 and LDB3 represents a key molecular distinction between DM1 and DM2.
  • Differential myosin isoform expression in atrophic fibers contributes to the distinct muscle pathology in DM1 and DM2.
  • Aberrant protein translation and/or turnover may also play a role in the pathogenesis of myotonic dystrophies.

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
The Sarcomere01:08

The Sarcomere

A sarcomere is a microscopic segment repeating in a myofibril. The sarcomere fundamentally consists of two main myofilaments: thick filaments called myosin and thin filaments called actin. These filaments interact by sliding past each other in response to stimulus. In addition to myosin and actin, several other proteins, such as tropomyosin, troponin, titin, nebulin, myomesin, α-actinin, and dystrophin, play crucial roles in regulating, structuring, and functioning of the sarcomere.
Each myosin...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...